secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2021-12-22T23:59:59+00:00
Accession:  0001104659-21-152721
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health names COO, collaborates with Mount Sinai on pain trial, shifts HQ to Hayward
--------------------------------------------------------------------------------

- Ryan Sabia appointed COO effective Dec 21, 2021; base salary $250,000/yr plus up to 25% bonus.
- Board approved annual director compensation plan: $35,000 retainer plus additional fees for chair roles.
- Collaborating with Icahn School of Medicine at Mount Sinai for double-blind RCT on bioelectronic post-surgery pain management.
- Principal place of business moved to 25821 Industrial Blvd, Suite 100, Hayward, CA 94545.
- Mindgruve named digital marketing agency of record to support ecommerce and brand strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000110465921152721/0001104659-21-152721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000110465921152721/tm2136151d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-152721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer